• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EBioMedicine . Immunodominance hierarchy of influenza A haemagglutinin antigenic sites: an observational cohort study across distinct exposure histo

tetano

Editor, Senior Moderator
EBioMedicine


. 2026 Aug 6:131:106412.
doi: 10.1016/j.ebiom.2026.106412. Online ahead of print.
Immunodominance hierarchy of influenza A haemagglutinin antigenic sites: an observational cohort study across distinct exposure histories

José Luis Martínez-Guevara[SUP] 1 [/SUP], Tsoi Ying Lai[SUP] 1 [/SUP], Mitali Mishra[SUP] 1 [/SUP], Minh Thu Hoang[SUP] 1 [/SUP], William Shea[SUP] 1 [/SUP], Caroline Katherine Page[SUP] 1 [/SUP], Pamela Sinywimaanzi[SUP] 2 [/SUP], Edgar Simulundu[SUP] 2 [/SUP], Richard Eric Rothman[SUP] 3 [/SUP], Andrew Pekosz[SUP] 4 [/SUP], Katherine Zela Joan Fenstermacher[SUP] 3 [/SUP], Catherine Gayle Sutcliffe[SUP] 5 [/SUP], Viviana Simon[SUP] 6 [/SUP], Peter Palese[SUP] 7 [/SUP], Weina Sun[SUP] 8 [/SUP], Irene González-Domínguez[SUP] 9 [/SUP]


Affiliations
Free article Abstract

Background: Antibody responses to influenza A viruses are strongly focused on immunodominant antigenic sites within the haemagglutinin (HA) head domain. Although immunodominance hierarchies have been described for H1 and H3 subtypes in adults, it remains unclear whether these patterns are shaped by first early-life exposure or by cumulative influenza infections or vaccinations over time.
Methods: We evaluated HA antigenic site immunodominance using haemagglutination inhibition (HI) assays with panels of H1 and H3 mutant viruses lacking individual classical antigenic sites. Sera from two human cohorts with different exposure histories were analysed: adults from New York City with mixed exposures through vaccination and infection, as well as children and adults living in rural Zambia exposed only through infection. Analyses of children with presumed first exposure were conducted to assess how initial influenza exposure shapes immunodominance hierarchies.
Findings: Across both cohorts, H1-specific antibody responses were consistently dominated by antigenic sites Sb and Ca2, regardless of age, geography, or exposure history. For H3, sites A and B shared immunodominance. The first influenza A infection in children was associated with the establishment of these hierarchies. Importantly, influenza B infection did not alter the immunodominance profiles of influenza A H1 or H3 haemagglutinin.
Interpretation: Immunodominance hierarchies of influenza A haemagglutinin antigenic sites are established early in life following first exposure and appear not to be substantially affected by diverse exposure histories.
Funding: This project was financially supported by Center for Excellence on Influenza Research and Response, the Center of Excellence for Influenza Research and Surveillance, the Collaborative Influenza Vaccine Innovation Centers programme as well as institutional funds from the Center for Vaccine Research and Pandemic Preparedness, and the National Institute of Allergy and Infectious Diseases.

Keywords: Antibody prevalence; Epitope targeting; Humoural immunity; Immune imprinting; Original antigenic sin; Protection.

 
Back
Top